1 |
Zhou P, Hu H, Lu Y, Xiao J, Wang Y, Xun Y, Xu J, Liu C, Wang S, Hu J. Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy. Molecular Therapy - Oncolytics 2022;27:167-181. [DOI: 10.1016/j.omto.2022.10.005] [Reference Citation Analysis]
|
2 |
Raghubar AM, Roberts MJ, Wood S, Healy HG, Kassianos AJ, Mallett AJ. Cellular milieu in clear cell renal cell carcinoma. Front Oncol 2022;12:943583. [DOI: 10.3389/fonc.2022.943583] [Reference Citation Analysis]
|
3 |
Subramanian A, Zakeri P, Mousa M, Alnaqbi H, Alshamsi FY, Bettoni L, Damiani E, Alsafar H, Saeys Y, Carmeliet P. Angiogenesis goes computational – The future way forward to discover new angiogenic targets? Computational and Structural Biotechnology Journal 2022;20:5235-55. [DOI: 10.1016/j.csbj.2022.09.019] [Reference Citation Analysis]
|